Intrinsic4D Announces Default on Outstanding Debentures, CEO and Director Resignations and Financial Status and Solvency
February 22, 2017 09:28 ET
|
Intrinsic4D Inc.
TORONTO, ONTARIO--(Marketwired - Feb. 22, 2017) -
NOT FOR DISSEMINATION IN THE U.S. OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES
Intrinsic4D Inc. (the "Corporation")...
Garðabær - ársreikningur 2016 - áætlun um birtingu
February 22, 2017 09:28 ET
|
Garðabær
Það tilkynnist hér með að Garðabær áætlar að birta ársreikning fyrir árið 2016
í viku 11, nánar tiltekið þriðjudaginn 14. mars 2017....
IT – Genium INET 5.0.0210 MiFID II/MiFIR Announcement (10/17)
February 22, 2017 09:28 ET
|
Nasdaq Commodities
Nasdaq would like to announce Genium INET 5.0.0210 going live November 20th, 2017.
This release will ensure that Genium INET is MiFID II compliant on January 3rd, 2018 and will contain mandatory...
IT – Genium INET 5.0.0210 MiFID II/MiFIR Announcement (10/17)
February 22, 2017 09:25 ET
|
Derivatives
Nasdaq would like to announce Genium INET 5.0.0210 going live November 20th, 2017.
This release will ensure that Genium INET is MiFID II compliant on January 3rd, 2018 and will contain mandatory...
Cavotec SA - Notice of Ordinary General Meeting
February 22, 2017 09:20 ET
|
Cavotec SA
The Shareholders of Cavotec SA are invited to attend the Ordinary General Meeting (OGM) to be held on Wednesday, March 29, 2017 at 15.00 (CET) at the offices of Cavotec SA, via Balestra 27, 6900...
Aurvista Gold Corporation Update: 30,000M Drilling Campaign at the Douay Gold Project
February 22, 2017 09:19 ET
|
Aurvista Gold Corporation
MONTREAL, QUEBEC--(Marketwired - Feb. 22, 2017) - Aurvista Gold Corporation ("Aurvista" or the "Company") (TSX VENTURE:AVA)(OTCQB:ARVSF)(FRANKFURT:AV2) is pleased to update shareholders...
Kalytera Therapeutics Announces Encouraging Results of a Phase 2a Clinical Study for the Treatment of Acute Graft versus Host Disease
February 22, 2017 09:18 ET
|
Kalytera Therapeutics, Inc.
VANCOUVER, British Columbia, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSXV:KALY) (“Kalytera”) is pleased to announce encouraging results from a Phase 2a study evaluating the...
Changes in AS “Citadele banka” Supervisory Board
February 22, 2017 09:15 ET
|
Citadele banka
David Shuman has declared his resignation from the position of the Member of the Supervisory Board of AS „Citadele banka”, following decision to engage in other activities. Supervisory Board is...
PolarityTE(TM) Inc. Regains Compliance With NASDAQ Independent Director Requirement
February 22, 2017 09:15 ET
|
PolarityTE, Inc.
SOUTH PLAINFIELD, NJ--(Marketwired - Feb 22, 2017) - PolarityTE™, Inc., (NASDAQ: COOL) ("PolarityTE™", or the "Company") today announced it has received formal notification from the...
Cavotec SA - Nomination Committee announcement
February 22, 2017 09:15 ET
|
Cavotec SA
According to Art.13 of the current Articles of Association, as well as according to Art.3 of the Federal Ordinance on Excessive Compensation, the directors are elected each year to hold office...